Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.06B | 15.01B | 17.32B | 13.48B | 8.95B | Gross Profit |
1.61B | 5.14B | 8.57B | 5.08B | 1.33B | EBIT |
-9.00M | 4.37B | 6.99B | 4.85B | 438.00M | EBITDA |
1.78B | 5.88B | 8.44B | 6.37B | 648.00M | Net Income Common Stockholders |
406.00M | 2.41B | 3.32B | 2.87B | -944.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.59B | 744.00M | 1.88B | 1.43B | 450.00M | Total Assets |
47.04B | 56.19B | 52.36B | 47.37B | 41.28B | Total Debt |
9.96B | 11.09B | 10.02B | 9.33B | 7.88B | Net Debt |
2.38B | 10.35B | 8.13B | 7.90B | 7.43B | Total Liabilities |
19.94B | 27.90B | 25.85B | 23.59B | 20.57B | Stockholders Equity |
26.08B | 26.99B | 25.47B | 23.00B | 20.04B |
Cash Flow | Free Cash Flow | |||
155.00M | -1.70B | 2.52B | 25.00M | -2.06B | Operating Cash Flow |
2.79B | 4.08B | 7.98B | 4.74B | 1.56B | Investing Cash Flow |
6.17B | -4.76B | -5.68B | -4.82B | -3.67B | Financing Cash Flow |
-2.56B | -469.00M | -1.99B | 1.06B | 1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | C$1.17B | 8.50 | 30.99% | 9.78% | 86.03% | 117.03% | |
69 Neutral | $18.61B | 31.19 | 9.67% | ― | ― | 137.28% | |
66 Neutral | C$1.23B | 11.95 | 19.20% | 1.35% | -27.13% | 987.10% | |
61 Neutral | C$24.29B | 70.09 | 1.40% | 1.00% | -22.39% | -77.05% | |
52 Neutral | C$2.06B | ― | -141.24% | ― | ― | -19.29% | |
49 Neutral | $1.96B | -1.23 | -21.20% | 3.72% | 0.95% | -28.96% | |
46 Neutral | C$1.45B | ― | -3.01% | ― | ― | 8.92% |